BIONDVAX PHARMACEUTICALS LTD
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for BIONDVAX PHARMACEUTICALS LTD *W EXP 05/15/202, CUSIP 09073Q113.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for BIONDVAX PHARMACEUTICALS LTD *W EXP 05/15/202, CUSIP 09073Q113.